Company Snapshot

Read it, Learn it and Do it for your investment Needs
Home > Market > Equity > Company Snapshot
Company Snapshot
Aurobindo Pharma Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code: 524804 NSE Symbol: AUROPHARMA P/E : 34.01
ISIN Demat: INE406A01037 Div & Yield %: 0.28 EPS : 41.81
Book Value: 391.14 Market Cap (Rs. Cr.): 82,595.80 Face Value : 1

Exchange

Stock Price Details
Last Price (₹) 1,415.40
Change 27.00 (1.94%)
Best Buy (₹) 0
Best Sell (₹) 0
Today's Range 1,404.20 - 1,432.75
52-Week Range 1,017.00 - 1,550.00
Beta (1 Year) 0.47
Chart
1 Day | 5 Day | 3 Month | 1 Year | 5 Year
Index Details
BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Midcap
Corporate Announcements
Aurobindo Pharma slides after USFDA classifies Eugia Unit-III as OAI
Aurobindo Pharma Ltd leads losers in 'A' group
Aurobindo Pharma's Eugia Unit-III receives OAI classification from USFDA
Aurobindo Pharma gains after receiving USFDA approval for Tofacitinib tablets
Aurobindo Pharma receives USFDA approval for Tofacitinib Tablets
USFDA classifies Eugia Pharma Specialities' Telangana unit inspection as Official Action Indicated
Aurobindo Pharma consolidated net profit rises 1.97% in the March 2026 quarter
Suraksha Diagnostic Ltd Falls 7.95%
Aurobindo Pharma Ltd up for third consecutive session
CuraTeQ Biologics receives CDSCO marketing authorisation for Bevqolva®
Corporate Details
Incorporation Year : 1986
Chairman : M R Kumar
Ownership Group : Indian Private
Sector : Pharmaceuticals
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
Registered Office :

Aurobindo Pharma Ltd
Plot No 2 Maitrivihar,
Behind Maithri Vanam Ameerpet,
Hyderabad,
Telangana - 500038,
Phone : 91-40-23736370,
Fax : 91-40-23747340
E-Mail : cs@aurobindo.com; investorgrievances@aurobindo.com
URL : http://www.aurobindo.com
Investor Returns
Period Date Price() Returns (%)
1Week 10-Jun-2026 1,453.90 -2.19
1Month 18-May-2026 1,501.65 -5.30
3Month 17-Mar-2026 1,287.40 10.46
6Month 17-Dec-2025 1,193.05 19.20
1Year 17-Jun-2025 1,109.50 28.17
Mutual Funds Holding
Scheme Name % Holding Market Value (₹.Cr)
HDFC Mid Cap Fund 1.96 1903.49
Quant ELSS Tax Saver Fund 7.26 948.88
Quant Mid Cap Fund 9.44 765.68
SBI Large & Midcap Fund 1.94 764.07
Quant Multi Cap Fund 7.92 607.26
Peer Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln
Company Last Price() Change(%) 52Week High() 52Week Low() Market Cap()
Sun Pharmaceutical Industries Ltd 1,819.95 1.07 1,917.15 1,547.25 436,666.97
Cipla Ltd 1,350.75 -1.60 1,672.20 1,165.55 109,119.71
Zydus Lifesciences Ltd 1,061.50 -1.57 1,119.00 835.85 106,811.74
Dr Reddys Laboratories Ltd 1,269.00 -0.63 1,376.00 1,149.00 105,919.50
Lupin Ltd 2,266.80 -0.45 2,492.00 1,838.65 103,645.47